Replacement of Chlorides with Dicarboxylate Ligands in Anticancer Active Ru(II)-DMSO Compounds: A New Strategy That Might Lead to Improved Activity
作者:Ioannis Bratsos、Barbara Serli、Ennio Zangrando、Nikos Katsaros、Enzo Alessio
DOI:10.1021/ic0613964
日期:2007.2.1
dicarb)] (dicarb = mal, 6; mmal, 9; ox, 14) that contains a chelating dicarboxylate unit and a residual chloride. Likewise, when 3 was used as a precursor, the neutral mononuclear species fac-[Ru(DMSO-O)(DMSO-S)3(eta2-dicarb)] (dicarb = mal, 7; mmal, 10; ox, 16), which contains a DMSO-O ligand in the place of Cl-, was obtained. On the contrary, K2(suc) and K2(dmmal) yielded preferentially the dinuclear
合成了一系列新的含二羧酸酯配体(dicarb)的Ru(II)-DMSO配合物,即草酸酯(ox),丙二酸酯(mal),丙二酸甲酯(mmal),丙二酸二甲酯(dmmal)和琥珀酸酯(suc)。结构特征。这些化合物是从已知的Ru(II)-Cl-DMSO抗癌复合物cis,fac- [RuCl2(DMSO-S)3(DMSO-O)](1)和反式-[RuCl2(DMSO-S)4]制备的(2)和不含氯的前体fac- [Ru(DMSO-S)3(DMSO-O)3] [CF3SO3] 2(3),目的是评估阴离子配体的性质如何影响生物这些物种的活动。基本上,所研究的配体可以分为两组。1或2与K2(dicarb)(dicarb = ox,mal,mmal)的反应优先产生单核种[K] fac- [RuCl(DMSO-S)3(eta2-dicarb)](dicarb = mal, 6; mmal,9;黄牛,14)含有螯